Innospec (IOSP) Liabilities and Shareholders Equity (2010 - 2026)

Innospec has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $1.8 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $1.8 billion, up 2.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.3 billion (up 3.57% YoY), and the FY2025 annual result was $1.8 billion, up 5.63% from the prior year.
• Liabilities and Shareholders Equity came in at $1.8 billion for Q1 2026 at Innospec, down from $1.8 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.8 billion in Q4 2025 to a low of $1.6 billion in Q4 2022.
• The 5-year median for Liabilities and Shareholders Equity is $1.7 billion (2023), against an average of $1.7 billion.
• Across the five-year window, Liabilities and Shareholders Equity climbed 13.86% in 2022 and fell 3.03% in 2023, its largest moves.
• Innospec's Liabilities and Shareholders Equity stood at $1.6 billion in 2022, then advanced by 6.47% to $1.7 billion in 2023, then rose by 1.6% to $1.7 billion in 2024, then rose by 5.63% to $1.8 billion in 2025, then dropped by 0.69% to $1.8 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.